Withdrawal versus continuous cyclosporine therapy in kidney transplant recipients of one-haplotype-matched donors

被引:3
|
作者
Chew-Wong, A
Alberú, J
Abasta-Jiménez, M
Alvarez-Sandoval, E
Gabilondo-Navarro, F
Correa-Rotter, R
机构
[1] Inst Nacl Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14000, DF, Mexico
[2] Inst Nacl Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14000, DF, Mexico
[3] Inst Nacl Nutr Salvador Zubiran, Dept Transplant, Mexico City 14000, DF, Mexico
[4] Inst Nacl Nutr Salvador Zubiran, Dept Urol, Mexico City 14000, DF, Mexico
关键词
D O I
10.1016/S0041-1345(98)01922-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1106 / 1109
页数:4
相关论文
共 50 条
  • [1] Defining the risk of elective cyclosporine withdrawal in stable kidney transplant recipients
    Anjum, S
    Andany, MA
    McClean, JC
    Danielson, B
    Kasiske, BL
    AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (02) : 179 - 185
  • [2] A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine a combination therapy
    Mahalati, K
    Kahan, BD
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3232 - 3233
  • [3] CYCLOSPORINE WITHDRAWAL IN RENAL-TRANSPLANT RECIPIENTS MAINTAINED ON TRIPLE THERAPY
    ABOUNA, GM
    KUMAR, SMA
    WHITE, AG
    SAMHAN, M
    KALAWI, M
    ALSABAWI, N
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1009 - 1010
  • [4] Use of sirolimus to facilitate cyclosporine avoidance or steroid withdrawal in kidney transplant recipients
    Hricik, DE
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 73S - 78S
  • [5] Effect of cyclosporine withdrawal on IL-10 production in kidney transplant recipients
    Alberlú, J
    Richaud-Patin, Y
    Mancilla, E
    Díliz, H
    Correa-Rotter, R
    Chew-Wong, A
    Uribe, N
    de Leo, C
    Llorente, L
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 2024 - 2027
  • [6] One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine
    El Haggan, W
    Barthe, N
    Vendrely, B
    Chauveau, P
    Berger, F
    Aparicio, M
    Potaux, L
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1817 - 1818
  • [7] Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients
    ElGhoroury, M
    Hariharan, S
    Peddi, VR
    Munda, R
    Schroeder, TJ
    Demmy, AM
    Alexander, JW
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 649 - 651
  • [8] ELECTIVE CYCLOSPORINE WITHDRAWAL IN RENAL-TRANSPLANT RECIPIENTS MAINTAINED ON TRIPLE THERAPY
    KEITEL, E
    BITTAR, AE
    LOSEKANN, A
    DEBONI, L
    CERETTA, F
    GOLDANI, JC
    GARCIA, VD
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (06) : 2606 - 2608
  • [9] Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study
    Ahsan, N
    Hricik, D
    Matas, A
    Rose, S
    Tomlanovich, S
    Wilkinson, A
    Ewell, M
    McIntosh, M
    Stablein, D
    Hodge, E
    Hayes, D
    Gores, P
    Cohen, D
    Gonwa, T
    Brinler, K
    Harland, R
    Neylan, J
    Pescovitz, M
    Wynn, J
    Ahsan, N
    Yang, HC
    Bennett, W
    Copley, J
    Wilkinson, A
    Dunn, J
    Tomlanovich, S
    Chan, L
    Bertolatus, JA
    Weir, M
    Mendez, R
    Pirsch, J
    Helderman, JH
    TRANSPLANTATION, 1999, 68 (12) : 1865 - 1874
  • [10] PREDNISONE WITHDRAWAL IN HLA IDENTICAL AND ONE HAPLOTYPE-MATCHED LIVE-RELATED DONOR AND CADAVER RENAL-TRANSPLANT RECIPIENTS
    HARIHARAN, S
    SCHROEDER, TJ
    WEISKITTEL, P
    ALEXANDER, JW
    FIRST, MR
    KIDNEY INTERNATIONAL, 1993, 44 : S30 - S35